present
total
fulllength
genom
sequenc
submit
gisaid
among
one
releas
genbank
access
ji
et
al
coronavirus
classifi
four
subfamili
base
genet
properti
alpha
beta
gamma
deltacoronaviru
sarscov
merscov
belong
genu
betacoronaviru
induc
sever
respiratori
diseas
human
hilgenfeld
peiri
phylogenet
analysi
genom
sequenc
coronaviru
deposit
genbank
reveal
also
belong
genu
betacoronaviru
display
closest
linkag
two
sarslik
coronavirus
bat
benvenuto
et
al
guo
et
al
wu
et
al
zhou
et
al
coronavirus
envelop
virus
singlestrand
rna
genom
posit
polar
spike
glycoprotein
protein
respons
receptor
bind
membran
fusion
angiotensinconvert
enzym
identifi
receptor
sarscov
surfac
human
cell
recent
research
demonstr
also
requir
entri
letko
munster
zhao
et
al
zhou
et
al
bind
affin
receptorbind
domain
rbd
protein
present
coronaviru
relat
viru
infect
pathogen
anoth
studi
show
comparison
human
sarscov
rbd
exhibit
much
lower
affin
indic
possibl
lower
virul
dong
et
al
addit
major
structur
protein
sarscov
genom
encod
sever
accessori
protein
play
import
role
rapid
evolut
hilgenfeld
peiri
encod
protein
exampl
learn
earli
stage
sarscov
outbreak
gene
code
singl
protein
middl
late
stage
epidem
gene
underw
gradual
nt
delet
code
two
separ
accessori
protein
hypothes
truncat
event
respons
increas
humanto
human
transmiss
effici
occur
late
stage
trigger
epidem
interestingli
nt
delet
sarscov
led
attenu
mutat
reduct
viru
replic
level
muth
et
al
oostra
et
al
perhap
attenu
potenti
reason
possibl
eventu
extinguish
outbreak
unfortun
genom
sequenc
show
intact
gene
undergo
gradual
loss
mutat
subsequ
viru
circul
human
outbreak
could
sever
earli
stage
outbreak
peopl
reliabl
understand
suscept
viru
antivir
drug
look
back
medic
use
fight
sarscov
initi
ribavirin
recogn
wide
activ
antivir
drug
effect
rang
rna
virus
littl
use
sar
patient
vitro
activ
ribavirin
replic
sarscov
highli
variabl
depend
type
cell
use
assay
mani
sar
patient
treat
combin
ribavirin
corticosteroid
given
poor
prognosi
link
drug
side
effect
cinatl
et
al
countri
interferon
alpha
use
combin
immunoglobulin
thymosin
therapeut
effect
zhao
et
al
addit
report
interferon
beta
significantli
better
also
polyethylen
glycolmodifi
prevent
sarscov
infect
reduc
viral
replic
reduc
histopatholog
treatment
cinatl
et
al
haagman
et
al
identifi
potenti
drug
viral
proteas
mpro
model
prof
zihe
rao
group
tsinghua
univers
beij
china
select
seri
potenti
drug
exist
market
selfbuilt
databas
highcost
medicin
compound
medicin
plant
sourc
databas
compound
thirti
drug
candid
consist
biolog
activ
natur
product
tradit
chines
medicin
drug
potenti
show
therapeut
effect
chosen
test
clinic
treatment
pneumonia
patient
infect
base
previou
antisar
studi
comput
simul
older
drug
like
cinnamon
thiamin
cyclosporin
csa
could
effect
immunosuppress
drug
csa
prevent
nucleocapsid
protein
viru
bind
cyclophilin
cypa
host
cell
peptidyl
prolyl
cistran
isomeras
ppias
activ
combin
interferon
csa
shown
previous
significantli
inhibit
replic
tissu
damag
caus
coronaviru
infect
bronchi
lung
human
pfefferl
et
al
detect
specif
interact
cypa
sarsncov
nonstructur
protein
yeasttwohybrid
proteinprotein
interact
techniqu
also
test
drug
csa
varieti
coronavirus
identifi
pancoronaviru
inhibitor
haagman
et
al
sinc
mani
inhibitor
design
synthes
act
coronaviru
experienc
systemat
toxic
preclin
studi
compound
yet
use
clinic
trial
prevent
recurr
sarscov
one
main
difficulti
drug
develop
global
public
health
concern
focus
number
known
wellcharacter
infect
howev
outbreak
pneumonia
caus
novel
viru
remind
import
given
predict
risk
novel
viru
infect
human
thompson
outbreak
continu
risk
model
need
help
refin
risk
assess
piec
togeth
emerg
data
permit
regular
refin
ensur
optim
manag
patient
healthi
popul
present
complet
genom
differ
releas
latest
publish
inform
genom
provid
peerreview
inform
urgent
need
improv
risk
assess
respons
occur
real
time
chen
et
al
riou
althau
possibl
humantohuman
transmiss
viru
still
investig
understand
transmiss
characterist
potenti
sustain
humantohuman
transmiss
critic
import
coordin
current
screen
contain
strategi
determin
whether
outbreak
constitut
public
health
emerg
intern
concern
situat
sever
urgent
us
need
better
understand
toward
viru
prevent
control
order
better
understand
earli
transmiss
pattern
julien
et
al
conduct
random
simul
studi
earli
outbreak
trajectori
consist
epidemiolog
find
date
riou
althau
suggest
rapid
establish
sustain
transmiss
chain
singl
case
rule
stage
particularli
attent
given
prevent
superspread
event
chen
et
al
report
mathemat
model
simul
transmiss
novel
wuhan
coronaviru
batshostsreservoirpeopl
transmiss
network
model
simul
potenti
transmiss
infect
sourc
human
chen
et
al
anoth
studi
datadriven
analysi
earli
phase
outbreak
conduct
zhao
et
al
preliminari
estim
basic
reproduct
number
made
estim
transmiss
via
basic
reproduct
number
base
data
earli
stage
outbreak
zhao
et
al
howev
mani
import
aspect
viru
biolog
whether
viru
travel
across
contin
list
speci
infect
whether
caus
sever
mortal
much
harder
forecast
premis
amount
sequenc
data
current
avail
latest
advanc
comput
method
use
data
make
possibl
first
time
gener
virtual
model
virus
evolv
environ
virus
behav
model
potenti
make
risk
assess
aris
use
inform
polici
direct
strategi
head
impend
threat
date
mani
problem
remain
solv
includ
viru
origin
extent
durat
transmiss
human
abil
infect
anim
host
spectrum
pathogenesi
human
infect
effect
vaccin
develop
heart
vaccin
develop
question
immunolog
crucial
understand
immunolog
question
associ
viral
infect
clinic
characterist
treatment
sar
suggest
seriou
problem
immunopatholog
particularli
lung
mucosa
complex
uniqu
might
due
fact
systemat
protect
immun
respons
enough
protect
viral
infect
current
one
danger
valuabl
experi
perform
test
immun
cell
blood
lung
infect
patient
prefer
differ
stage
viral
infect
data
clinic
immun
lay
foundat
futur
vaccin
develop
need
awar
challeng
concern
pose
commun
everi
effort
made
understand
control
diseas
author
declar
conflict
interest
articl
contain
studi
human
anim
subject
perform
author
articl
licens
creativ
common
attribut
intern
licens
permit
use
share
adapt
distribut
reproduct
medium
format
long
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licenc
indic
chang
made
imag
third
parti
materi
articl
includ
articl
creativ
common
licenc
unless
indic
otherwis
credit
line
materi
materi
includ
articl
creativ
common
licenc
intend
use
permit
statutori
regul
exce
permit
use
need
obtain
permiss
directli
copyright
holder
view
copi
licenc
visit
http
